Proffitt & Goodson’s Fulgent Genetics FLGT Stock Holding History

Proffitt & Goodson’s Portfolio FLGT Stock Details FLGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-200	Closed	-$3.69K	–	266
2024 Q4	$3.69K	Buy	+200	New	+$3.9K	﹤0.01%	229

Other funds holding FLGT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

PWAM

Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Proffitt & Goodson's FLGT Position: Q1 2025 in Review

Proffitt & Goodson sold out of Fulgent Genetics (FLGT) in Q1 2025, closing a stake of 200 shares — an estimated $3.69K sold.

Proffitt & Goodson first reported a position in FLGT in Q4 2024 and held it in 1 quarter. The position peaked at $3.69K in Q4 2024. 176 funds tracked by Wall St. Rank hold FLGT as of Q1 2025.

Proffitt & Goodson reported no remaining Fulgent Genetics position as of Q1 2025 after selling out during the quarter.
Proffitt & Goodson sold 200 Fulgent Genetics shares in Q1 2025, an estimated $3.69K.
Proffitt & Goodson first reported a position in Fulgent Genetics in Q4 2024 and held it in 1 quarter.
Proffitt & Goodson's Fulgent Genetics position peaked at $3.69K in Q4 2024.
176 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2025.

Based on Proffitt & Goodson's 13F filing for Q1 2025, filed 29 Apr 2025.